The present invention represents an in vitro implementable method and related kit for assessing the response to immune tolerance restoration therapy by evaluating the expression of specific microRNAs (miRNAs) as biomarkers of residual beta-cell function
Research Institution:
Università degli Studi di Siena
Priorities and sectors:
Life Sciences
